Health Action International’s mission is:
a. to promote rational and economic medicines policy, therapy and use ... […]
b. to support networks, countries, groups and individuals supporting the objectives described (above). … […]…, in the broadest sense.
(HAI Foundation Document (amended 2007), Article 2.1, pg1, 1988, Amsterdam) (See Annex III)
Goal: Health Action International (HAI) is working towards a world where all people, especially the poor and disadvantaged, are able to exercise their human right to health. HAI’s goal is to achieve universal and equitable access to affordable essential medicines of assured quality and that those medicines are used rationally throughout the world.
Vision: HAI and its global partners recognise that poverty and social injustice are the greatest barriers to health and sustainable development. Partners are working for just societies where people can participate equitably in all decision making that affects their health and well being, including the allocation of resources. HAI recognises that it is only when societies enjoy sustainable levels of good health that citizens can take a full and active part in development– for development to succeed, citizens need to enjoy sustainable and predictable health and well-being.

Specific objective
Reveal reimbursement systems that are a barrier to access to medicines and promote reimbursement/healthcare funding best practice

Activity
Together with HAI members in different European countries, including CEE and South Europe where relevant, develop three case studies on specific problems with access to medicines due to reimbursement schemes (incl. Health Care Reforms). Develop policy recommendations and support advocacy to guarantee access to essential medicines in these areas.

Specific Activity
To develop a blueprint for one-day sub-regional workshops on medicines reimbursement and barriers to treatment Pilot one-day sub-regional workshops on medicines reimbursement and barriers to treatment (twice)
Establish workshops in sustainable future work programme

Health & Social Outcomes
Social Outcomes: Engagement of civil society in medicines policy; re-prioritisation of public resources; medicine policy reoriented to public health.
Health Outcomes: Improved treatment outcomes, reduced morbidity, reduced mortality,

Intermediate Health Outcomes (modifiable determinants of health) Healthy Lifestyles;
Individual pharmaceutical treatment awareness,
Reduction in irrational lifestyle medicines use
Lifestyle changes as an alternative to pharmaceutical therapy
Reduction in Adverse Drug Reactions

Effective Health Services
Rational medicines policies are accepted by patients, consumers, health professionals and governments
International Intellectual Property (IP) rights legislation reflect public health service priorities over commercial interests
Reimbursed health services provide equitable and universal access to essential medicines
Free Trade Agreements (FTAs) reflect an improvement in access to medicines